Cargando…
Increased efficacy of photodynamic therapy of R3230AC mammary adenocarcinoma by intratumoral injection of Photofrin II.
Photodynamic therapy consists of the systemic administration of a derivative of haematoporphyrin (Photofrin II) followed 24-72 h later by exposure of malignant lesions to photoradiation. We investigated the efficacy of this treatment after direct intratumoral injection of Photofrin II. This direct t...
Autores principales: | Gibson, S. L., van der Meid, K. R., Murant, R. S., Hilf, R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971366/ https://www.ncbi.nlm.nih.gov/pubmed/2139578 |
Ejemplares similares
-
In vitro photosensitization of tumour cell enzymes by photofrin II administered in vivo.
por: Gibson, S. L., et al.
Publicado: (1989) -
Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma.
por: Meyer, R. E., et al.
Publicado: (1995) -
Effects of diethylamine/nitric oxide on blood perfusion and oxygenation in the R3230Ac mammary carcinoma.
por: Shan, S. Q., et al.
Publicado: (1997) -
Response of Photofrin-sensitised mesothelioma xenografts to photodynamic therapy with 514 nm light.
por: Foster, T. H., et al.
Publicado: (1996) -
Photodynamic Therapy of Lung Cancer With Bronchial Artery Infusion of Photofrin
por: Okunaka, Tetsuya, et al.
Publicado: (1996)